Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents
- PMID: 32372952
- PMCID: PMC7184885
- DOI: 10.3389/fphar.2020.00413
Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents
Abstract
Based on recent findings, an increased late sodium current (INa,late) plays an important pathophysiological role in cardiac diseases, including rhythm disorders. The article first describes what is INa,late and how it functions under physiological circumstances. Next, it shows the wide range of cellular mechanisms that can contribute to an increased INa,late in heart diseases, and also discusses how the upregulated INa,late can play a role in the generation of cardiac arrhythmias. The last part of the article is about INa,late inhibiting drugs as potential antiarrhythmic agents, based on experimental and preclinical data as well as in the light of clinical trials.
Keywords: antiarrhythmic drugs; arrhythmias; late sodium current; sodium channel inhibitors; voltage gated sodium channel.
Copyright © 2020 Horváth, Hézső, Kiss, Kistamás, Magyar, Nánási and Bányász.
Figures


Similar articles
-
The late sodium current in heart failure: pathophysiology and clinical relevance.ESC Heart Fail. 2014 Sep;1(1):26-40. doi: 10.1002/ehf2.12003. ESC Heart Fail. 2014. PMID: 28834665 Review.
-
Late INa Inhibition as an Antiarrhythmic Strategy.J Cardiovasc Pharmacol. 2017 Sep;70(3):159-167. doi: 10.1097/FJC.0000000000000510. J Cardiovasc Pharmacol. 2017. PMID: 28654510 Review.
-
Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia.Pharmacol Rep. 2024 Jun;76(3):585-599. doi: 10.1007/s43440-024-00597-2. Epub 2024 Apr 15. Pharmacol Rep. 2024. PMID: 38619735
-
Late sodium current and calcium homeostasis in arrhythmogenesis.Channels (Austin). 2021 Dec;15(1):1-19. doi: 10.1080/19336950.2020.1854986. Channels (Austin). 2021. PMID: 33258400 Free PMC article. Review.
-
An emerging antiarrhythmic target: late sodium current.Curr Pharm Des. 2015;21(8):1073-90. doi: 10.2174/1381612820666141029111729. Curr Pharm Des. 2015. PMID: 25354179 Review.
Cited by
-
Arrhythmogenic Remodeling in the Failing Heart.Cells. 2021 Nov 17;10(11):3203. doi: 10.3390/cells10113203. Cells. 2021. PMID: 34831426 Free PMC article. Review.
-
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management.Vasc Health Risk Manag. 2020 Sep 14;16:353-365. doi: 10.2147/VHRM.S264130. eCollection 2020. Vasc Health Risk Manag. 2020. PMID: 32982263 Free PMC article. Review.
-
Store-Operated Ca2+ Entry as a Putative Target of Flecainide for the Treatment of Arrhythmogenic Cardiomyopathy.J Clin Med. 2023 Aug 14;12(16):5295. doi: 10.3390/jcm12165295. J Clin Med. 2023. PMID: 37629337 Free PMC article. Review.
-
Antiarrhythmic and Inotropic Effects of Selective Na+/Ca2+ Exchanger Inhibition: What Can We Learn from the Pharmacological Studies?Int J Mol Sci. 2022 Nov 24;23(23):14651. doi: 10.3390/ijms232314651. Int J Mol Sci. 2022. PMID: 36498977 Free PMC article. Review.
-
Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus.Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):18-25. doi: 10.1093/ehjcvp/pvac043. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35894858 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources